No abstract available
Keywords:
cyclophosphamide; glomerular and tubulointerstitial diseases; membranous; membranous glomerulonephritis; nephrotic syndrome; rituximab.
MeSH terms
-
Cyclophosphamide / adverse effects
-
Glomerulonephritis, Membranous* / drug therapy
-
Humans
-
Immunosuppressive Agents / adverse effects
-
Rituximab / adverse effects
Substances
-
Immunosuppressive Agents
-
Rituximab
-
Cyclophosphamide